2018 Patient Seminar - New York, NY, USA

Return to the main Patient Seminar page.

Welcome from HCLF President and Session: Foundational Understanding of HCL (Recording)

Session Moderator: Dr. Michael Grever, Ohio State University, USA

Panelists:

  • Dr. Graeme Quest, Queens University, Canada

  • Dr. James Johnston, Manitoba Institute of Cell Biology, Canada

  • Dr. Matthew Cross, Royal Marsden Hospital, United Kingdom

Session: Understanding variant HCL (Recording)

Session Moderator: Dr. Thorsten Zenz, University Hospital Zurich, Switzerland

Panelists:

  • Dr. Michael Grever, Ohio State University, USA

  • Dr. Kanti Rai, Zucker School of Medicine at Hofstra/Northwell, USA

  • Dr. Farhad Ravandi-Kashani, MD Anderson, USA

  • Dr. Sascha Dietrich, University of Heidelberg, Germany

  • Dr. Francesco Forconi, University of Southampton, United Kingdom

Session: HCL Patient Data Registry (RecordingPresentation Slides)

Presenters:

  • Dr. Leslie Andritsos, University of New Mexico, USA

  • Dr. Mirela Anghelina, Ohio State University, USA

Session: Dietary patterns and lifestyle for cancer prevention and integrative care (Recording)

Presenter: Dr. Rui Hai Liu, Cornell University, USA

Session: HCL Treatment – Emerging Therapies and Clinical Trials (Recording)

Moderator: Marc Stadtmauer, HCLF

Presenters:

  • Dr. Robert Kreitman, National Institutes of Health, USA

  • Dr. Thorsten Zenz, University Hospital Zurich, Switzerland

  • Dr. James Johnston, Manitoba Institute of Cell Biology, Canada

  • Dr. Sascha Dietrich, University of Heidelberg, Germany

  • Dr. Martin Tallman, Memorial Sloan Kettering Cancer Center

Session: Quality of Life for Patients with HCL (Recording)

Moderator: Dr. Claire Dearden, Royal Marsden Hospital, United Kingdom (Introductory Slides)

Panelists:

  • Dr. Leslie Andritsos, University of New Mexico, USA (Presentation Slides)

  • Dr. Mirela Anghelina, Ohio State University, USA

  • Dr. Leshia Howell, HCL Survivor, USA

  • Dr. Rui Hai Liu, Cornell University, USA

Wrap-up remarks: Anna Lambertson, HCLF